Industry Overview - The marijuana stock market is currently experiencing significant selling pressure, with many shareholders holding positions for extended periods and the sector trading at all-time lows [1] - Investors are adjusting their strategies and outlooks, recognizing that profitability alone may not be sufficient to drive market movement [1] Federal Reform Speculation - There has been a recent upward trend in marijuana stocks driven by speculation about potential federal reform regarding cannabis in the USA [2] - Unlike Canada, which has fully legalized cannabis, the USA is still progressing towards legalization [2][3] Key Companies to Watch - **Green Thumb Industries Inc. (OTC: GTBIF)**: This company manufactures and sells cannabis products for both medical and adult-use markets. It has recently expanded its presence in Pennsylvania with a new dispensary [4][6] - **Jushi Holdings Inc. (OTC: JUSHF)**: A vertically integrated cannabis company involved in cultivation, processing, retail, and distribution. It has modified a secured commercial loan to support capital expenditures and working capital [8][10] - **Greenlane Holdings, Inc. (NASDAQ: GNLN)**: Engages in the development and distribution of cannabis accessories and lifestyle products. The company reported a significant decline in total revenue for Q2 2025 compared to the previous year [10][12] Financial Performance Highlights - **Greenlane Holdings, Inc.**: Reported total revenue of $0.8 million for Q2 2025, down from $2.6 million in the prior year. Operating expenses decreased by 27% to $3.3 million, while the operating loss improved slightly to $3.3 million compared to $3.5 million in the previous year [12][14]

Industry Overview - The cannabis industry is experiencing increased trading activity, driven by speculation regarding federal reform and the potential for greater legitimacy [1][2][3] - Despite significant revenue generation, the industry still has room for growth and development, with hopes that regulatory changes will lead to more consistent trading of marijuana stocks [3] Company Highlights - **Green Thumb Industries Inc.**: Engages in the manufacturing, distribution, marketing, and sale of cannabis products, operating through Retail and Consumer Packaged Goods segments. Recently expanded its presence in Pennsylvania with a new RISE Dispensary, marking its 19th location in the state and 108th nationwide [4][6] - **Jushi Holdings Inc.**: A vertically integrated cannabis company involved in cultivation, processing, retail, and distribution for medical and adult-use markets in the U.S. [7] - **Greenlane Holdings, Inc.**: Focuses on the development and distribution of cannabis accessories and lifestyle products across the U.S., Canada, Europe, and Latin America. Reported Q2 2025 earnings in mid-August [9] Financial Performance - A company reported total revenue of $0.8 million for the recent quarter, a decline from $2.6 million in the same period last year. Operating expenses decreased by 27% to $3.3 million, while the operating loss improved slightly to $3.3 million from $3.5 million year-over-year. The net loss was $3.2 million, compared to a net loss of $0.6 million in the prior year [12]

Core Insights - Green Thumb Industries Inc. has opened its 108th cannabis retail location and started generating revenue from its four dispensaries in Minnesota, which is expected to contribute to increased revenues for the company [1]. Company Developments - The opening of the new retail location marks a significant milestone for Green Thumb Industries, expanding its footprint in the cannabis market [1]. - The revenue generation from the Minnesota dispensaries, although described as minor, is anticipated to positively impact the company's overall financial performance [1]. Industry Context - The cannabis sector continues to see growth with companies like Green Thumb Industries expanding their retail presence, indicating a robust market environment [1].

Core Insights - RISE Dispensaries, owned by Green Thumb Industries, has opened its 19th retail location in Pennsylvania, RISE Dispensary Lebanon, marking the 108th location nationwide [1][8] Company Expansion - The new dispensary is strategically located near Downtown Lebanon off Route 422, enhancing accessibility for patients [1][8] - RISE Dispensary Lebanon offers a variety of products from Green Thumb's portfolio, including RYTHM premium flower, full-spectrum vapes, concentrates, and topicals [2][5] Community Engagement - The grand opening event on October 3 will feature special promotions and will benefit the local non-profit organization, Making A Difference of Lebanon, PA [3][4][8] - The company emphasizes its commitment to community support and well-being through its operations [3][7] Operational Details - RISE Dispensary Lebanon will operate from 9 a.m. to 8 p.m. Monday to Saturday and 10 a.m. to 6 p.m. on Sundays, with online pre-ordering available for convenience [2][4] - Green Thumb Industries has been part of the Pennsylvania market since 2017 and operates a manufacturing facility in Danville [5]

Industry Overview - The cannabis industry has experienced significant growth since 2018, driven by legal reforms and increasing consumer demand [2] - Despite challenges from black market competition, the sector remains active, with ongoing speculation about the success of the legal market and potential federal reforms [2][3] Federal Reform Outlook - There is optimism regarding federal reform in the cannabis industry, with expectations that it will eventually pass due to substantial investments and efforts [3] - Historical trends indicate that federal reform positively impacts public sector performance, suggesting a potential turning point for marijuana stock investors [3] Company Highlights - **Green Thumb Industries Inc.**: Recently announced a $50 million share repurchase program, authorizing the buyback of up to 10,364,640 subordinate voting shares over the next 12 months [4][6] - **Curaleaf Holdings, Inc.**: Expanded its operations by opening two new stores in Florida and Ohio, reflecting its mission to enhance access to high-quality cannabis [7][10] - **Cresco Labs Inc.**: Conducted its annual general and special meeting, where the number of directors was fixed at seven, and nominees were elected by a majority of votes [10][12]

Core Viewpoint - Green Thumb Industries Inc. has authorized a $50 million share repurchase program to enhance shareholder value and maintain strategic flexibility in the expanding cannabis market [1][3]. Summary by Sections Share Repurchase Program - The program allows for the repurchase of up to 10,364,640 subordinate voting shares over the next 12 months [2]. - Previous repurchase efforts resulted in approximately 13.5 million shares being repurchased for $108 million since September 5, 2023 [2]. Management's Perspective - The CEO, Ben Kovler, emphasized that buying back stock at the right price is a key method for creating shareholder value and maintaining a strong market position [3]. - The new repurchase program will start on September 23, 2025, and end on September 22, 2026, with no obligation to purchase shares if better opportunities arise [3]. Financial Considerations - The company does not plan to incur debt to fund the share repurchase program, and the actual number of shares purchased will depend on market conditions [4]. - All repurchased shares will be returned to the treasury and canceled [4]. Company Overview - Green Thumb Industries is a leading national cannabis consumer packaged goods company, operating RISE Dispensaries and offering a range of branded products [5]. - Established in 2014, the company has 20 manufacturing facilities and 108 retail stores across 14 U.S. markets, employing approximately 4,800 people [5].

Adult-Use Cannabis Sales to Begin at 9:00 a.m. on September 17 at RISE Dispensaries in Brooklyn Park, Eagan, Mankato, New Hope, and WillmarCHICAGO and VANCOUVER, British Columbia, Sept. 15, 2025 (GLOBE NEWSWIRE) -- RISE Dispensaries, a rapidly growing cannabis retail chain owned by Green Thumb Industries Inc. (“Green Thumb” or the “Company”) (CSE: GTII) (OTCQX: GTBIF), today announced it will commence adult-use cannabis sales at Minnesota retail locations in Brooklyn Park, Eagan, Mankato, New Hope, and Will ...

Core Insights - The U.S. cannabis industry is rapidly maturing with larger markets and more efficient operators, despite ongoing federal restrictions on full legalization [1] - Federal policy changes are gradually occurring, indicating a potential long-term shift in the cannabis landscape [2] - State-level leaders are crucial for monitoring growth and investment opportunities in the cannabis sector [1][23] Federal Legalization Efforts - Cannabis remains illegal federally, but the Department of Justice is considering rescheduling it from Schedule I to Schedule III, which would acknowledge its medical use and lower abuse risk classification [2] - This rescheduling would not legalize recreational use but would ease research restrictions and reduce tax burdens under Section 280E [2] Banking Reform - The SAFER Banking Act aims to normalize banking for cannabis businesses, reducing cash usage and improving transparency [4] - This reform would provide legal protection for banks, allowing more institutions to serve the cannabis industry, thus lowering costs and enhancing capital access for operators [4] Growth Projections - Cannabis sales are projected to reach approximately $31.4 billion in 2024, with steady double-digit growth expected into 2025 [5] - By 2030, total sales are anticipated to exceed $67 billion, with some estimates reaching nearly $87 billion by 2035, contingent on expanded legalization and consumer shifts from the illicit market [5] State-Level Success Stories - **Michigan**: Market surpassed $3 billion in 2024, with strong demand despite falling prices due to competition [6] - **Missouri**: Sales reached $1.46 billion in 2024, driven by streamlined licensing and moderate taxes [7] - **Illinois**: Sales exceeded $2 billion in 2024, with tax revenues over $490 million, supported by social equity programs and strong urban demand [8] - **New Jersey**: Revenues surpassed $2 billion, benefiting from early access for medical operators [9] - **Florida**: Medical-only market with nearly 900,000 registered patients, showing significant sales potential [10] - **New York**: Sales on track to reach the billion-dollar mark, with improving licensing and supply chains [11] Tax Revenues and Community Impact - Since 2014, adult-use states have collected nearly $25 billion in tax revenue, supporting education, public health, and social equity initiatives [12] - Legal markets reduce illicit activity and provide consumers with tested and labeled products, benefiting communities through job creation and reinvestment [12] Future Considerations - Federal rescheduling and the SAFER Banking Act could significantly improve industry fundamentals [13] - State ballot measures and legislative sessions will influence growth trajectories, with tax debates being crucial for margins and expansion [13] Leading Companies - **Trulieve Cannabis Corp.**: Dominates Florida's medical market with over 190 dispensaries, reporting billions in annual revenue [15] - **Curaleaf Holdings Inc.**: Operates over 150 dispensaries across high-growth states, with strong revenue growth exceeding a billion dollars [17] - **Green Thumb Industries Inc.**: Operates more than 90 dispensaries, known for strong consumer brands and solid revenues above $1 billion annually [19][20] Investor Considerations - Investors should focus on efficient operators, evaluate tax structures, and consider municipal support [22] - Strong brands with consistent quality are likely to gain market share, and balance sheets will be critical post-280E reform [22]

Industry Overview - The cannabis industry in the USA is currently experiencing a significant push for federal reform, which has been a long-standing goal since states began legalizing cannabis. This reform is crucial but has also created challenges for investors and legal operators due to the grey area of legality [1][2] - Despite the ongoing challenges, the demand for cannabis continues to rise, supported by positive earnings reports from the second quarter of 2025 and renewed investor interest following comments from former President Trump regarding federal reform [2][3] Company Highlights - **Green Thumb Industries Inc.**: This company manufactures, distributes, markets, and sells cannabis products for both medical and adult use in the United States. Recently, it announced a transaction to sell certain consumer packaged goods brands to Agrify Corporation, along with a $45 million loan to Agrify [4][8] - **Curaleaf Holdings, Inc.**: Curaleaf has been selected for inclusion in the S&P/TSX Composite Index, effective September 22, 2025. This inclusion signifies a major milestone for the company, enhancing its visibility and positioning within the market [11][12] - **Cresco Labs Inc.**: The company recently closed a $325 million senior secured term loan refinancing with a 12.5% interest rate, maturing on August 13, 2030. This refinancing replaces a previous $360 million facility, aiming to reduce total debt and provide more flexibility for prepayment [12][14]

Core Viewpoint - Green Thumb Industries Inc. has entered into significant transactions with Agrify Corporation, including the sale of certain consumer packaged goods brands, a licensing agreement, and a loan arrangement, indicating a strategic move to enhance its market position in the cannabis industry [1][2][5]. Group 1: Transactions Overview - The company sold all equity interests in VCP IP Holdings, LLC to Agrify for a cash consideration of US$50 million, which includes brands such as RYTHM and Beboe [2]. - A Trademark and Recipe License Agreement was established, allowing Green Thumb to continue using certain intellectual property related to the brands, with a monthly license fee based on sales [3]. - The company extended a loan of US$45 million to Agrify, secured by a convertible note with a 10% annual interest rate, maturing on February 25, 2027 [5][6]. Group 2: Financial Details - The convertible note issued to Agrify will accrue interest payable in cash, shares, or pre-funded warrants, with a conversion price set at $29.475 per share [7]. - The note imposes customary covenants on Agrify, and in case of default, the interest rate will increase to 14% [6]. Group 3: Company Background - Green Thumb Industries is a leading national cannabis consumer packaged goods company, operating 20 manufacturing facilities and 108 retail stores across 14 U.S. markets, employing approximately 4,800 people [8].